Cargando…
Evidence for Establishing the Clinical Breakpoint of Cefquinome against Haemophilus Parasuis in China
Haemophilus parasuis can cause high morbidity and mortality in swine. Cefquinome possesses excellent antibacterial activity against pathogens causing diseases of the respiratory tract. This study aimed to establish the clinical breakpoint (CBP) of cefquinome against H. parasuis and to monitor the re...
Autores principales: | Mi, Kun, Sun, Da, Li, Mei, Hao, Haihong, Zhou, Kaixiang, Liu, Zhenli, Yuan, Zonghui, Huang, Lingli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912692/ https://www.ncbi.nlm.nih.gov/pubmed/33498972 http://dx.doi.org/10.3390/pathogens10020105 |
Ejemplares similares
-
Determination of Susceptibility Breakpoint for Cefquinome against Streptococcus suis in Pigs
por: Mi, Kun, et al.
Publicado: (2021) -
The Epidemiologic and Pharmacodynamic Cutoff Values of Tilmicosin against Haemophilus parasuis
por: Zhang, Peng, et al.
Publicado: (2016) -
Exploration of Clinical Breakpoint of Danofloxacin for Glaesserella parasuis in Plasma and in PELF
por: Xu, Zihui, et al.
Publicado: (2021) -
In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis
por: Xiao, Xia, et al.
Publicado: (2015) -
A physiologically based pharmacokinetic model to optimize the dosage regimen and withdrawal time of cefquinome in pigs
por: Mi, Kun, et al.
Publicado: (2023)